Steven George Hughes's most recent trade in Avidity Biosciences Inc was a trade of 2,208 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Aug. 22, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Avidity Biosciences Inc | Steven George Hughes | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Aug 2025 | 2,208 | 72,875 | - | - | Stock Option (Right to Buy) | |
| Avidity Biosciences Inc | Steven George Hughes | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 46.40 per share. | 22 Aug 2025 | 2,208 | 38,867 | - | 46.4 | 102,462 | Common Stock |
| Avidity Biosciences Inc | Steven George Hughes | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.16 per share. | 22 Aug 2025 | 2,208 | 41,075 | - | 10.2 | 22,433 | Common Stock |
| Avidity Biosciences Inc | Steven George Hughes | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Aug 2025 | 1,542 | 50,875 | - | - | Stock Option (Right to Buy) | |
| Avidity Biosciences Inc | Steven George Hughes | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.57 per share. | 13 Aug 2025 | 1,542 | 40,409 | - | 6.6 | 10,131 | Common Stock |
| Avidity Biosciences Inc | Steven George Hughes | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 46.66 per share. | 13 Aug 2025 | 1,542 | 38,867 | - | 46.7 | 71,950 | Common Stock |
| Avidity Biosciences Inc | Steven George Hughes | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 42.74 per share. | 06 Aug 2025 | 33,983 | 38,867 | - | 42.7 | 1,452,342 | Common Stock |
| Avidity Biosciences Inc | Steven George Hughes | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Aug 2025 | 17,667 | 75,083 | - | - | Stock Option (Right to Buy) | |
| Avidity Biosciences Inc | Steven George Hughes | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 42.74 per share. | 06 Aug 2025 | 17,667 | 72,850 | - | 42.7 | 755,040 | Common Stock |
| Avidity Biosciences Inc | Steven George Hughes | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.16 per share. | 06 Aug 2025 | 17,667 | 90,517 | - | 10.2 | 179,497 | Common Stock |
| Avidity Biosciences Inc | Steven George Hughes | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Aug 2025 | 12,334 | 52,417 | - | - | Stock Option (Right to Buy) | |
| Avidity Biosciences Inc | Steven George Hughes | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 42.74 per share. | 06 Aug 2025 | 12,334 | 72,850 | - | 42.7 | 527,122 | Common Stock |
| Avidity Biosciences Inc | Steven George Hughes | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.57 per share. | 06 Aug 2025 | 12,334 | 85,184 | - | 6.6 | 81,034 | Common Stock |
| Avidity Biosciences Inc | Steven George Hughes | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Aug 2025 | 11,283 | 73,342 | - | - | Stock Option (Right to Buy) | |
| Avidity Biosciences Inc | Steven George Hughes | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 42.74 per share. | 06 Aug 2025 | 11,283 | 72,850 | - | 42.7 | 482,205 | Common Stock |
| Avidity Biosciences Inc | Steven George Hughes | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.96 per share. | 06 Aug 2025 | 11,283 | 84,133 | - | 16.0 | 180,077 | Common Stock |
| Avidity Biosciences Inc | Steven George Hughes | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Aug 2025 | 6,167 | 74,000 | - | - | Stock Option (Right to Buy) | |
| Avidity Biosciences Inc | Steven George Hughes | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 42.74 per share. | 06 Aug 2025 | 6,167 | 72,850 | - | 42.7 | 263,561 | Common Stock |
| Avidity Biosciences Inc | Steven George Hughes | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.47 per share. | 06 Aug 2025 | 6,167 | 79,017 | - | 22.5 | 138,572 | Common Stock |
| Avidity Biosciences Inc | Steven George Hughes | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 31.06 per share. | 20 Mar 2025 | 9,578 | 72,850 | - | 31.1 | 297,491 | Common Stock |
| Avidity Biosciences Inc | Steven George Hughes | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 28.59 per share. | 21 Jan 2025 | 2,032 | 82,428 | - | 28.6 | 58,096 | Common Stock |
| Avidity Biosciences Inc | George Steven Hughes | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 28.60 per share. | 21 Jan 2025 | 1,915 | 84,460 | - | 28.6 | 54,760 | Common Stock |
| Avidity Biosciences Inc | Hughes George Steven | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2025 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Avidity Biosciences Inc | George Hughes Steven | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2025 | 25,000 | 86,375 | - | 0 | Common Stock |